71 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Relay Competitors or Alternatives

Relay's top competitors include Eikon, GD3 and InSilico Medicine.

Unlock 29 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Relay's company profile

Sanjiv K Patel

President & CEO

88/100
330
$1.6B
$10M
  • $1.6B
    $10M
  • 330
    $1.6B
  • $10M
  • 88/100
  • 330
  • $1.6B
  • $10M
View ProfileView
1
Relay's Competitor - Eikon logo

Roger M. Perlmutter

Chairman & CEO

87/100
25 - 100
$1.1B
$5M - 25M
  • $1.1B
    $5M - 25M
  • 25 - 100
    $1.1B
  • $5M - 25M
  • 87/100
  • 25 - 100
  • $1.1B
  • $5M - 25M
View ProfileView
2
Relay's Competitor - GD3 logo

Eli Mordechai

CEO

90/100
1 - 25
- -
$100K - 5M
  • - -
    $100K - 5M
  • 1 - 25
    - -
  • $100K - 5M
  • 90/100
  • 1 - 25
  • - -
  • $100K - 5M
View ProfileView
3
Relay's Competitor - InSilico Medicine logo

Aleksandrs Zhavoronkov

Co-CEO

97/100
250 - 500
$515.8M
$25M - 100M
  • $515.8M
    $25M - 100M
  • 250 - 500
    $515.8M
  • $25M - 100M
  • 97/100
  • 250 - 500
  • $515.8M
  • $25M - 100M
View ProfileView
4
Relay's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

69/100
83,000
$1B
$63.6B
  • $1B
    $63.6B
  • 83,000
    $1B
  • $63.6B
  • 69/100
  • 83,000
  • $1B
  • $63.6B
View ProfileView
5
Relay's Competitor - VIVUS logo

John Amos

CEO

88/100
100 - 250
$84.6M
$5M - 25M
  • $84.6M
    $5M - 25M
  • 100 - 250
    $84.6M
  • $5M - 25M
  • 88/100
  • 100 - 250
  • $84.6M
  • $5M - 25M
View ProfileView
Relay's top 32 competitors are Eikon, GD3, InSilico Medicine, Voyager, Pfizer, VIVUS, CalciMedica, Roche, Orexigen Therapeutics, Inc., Lilly, Alvine Pharmaceuticals, Novoron Bioscience, Auspex Pharmaceuticals, Minerva Neurosciences, Athersys, AstraZeneca, Therapure, Novartis, Acceleron, Domain Therapeutics, Escient, Oncimmune, Genentech, Array BioPharma, Akili, Surface Oncology, Jounce, Mesoblast, Cadent Therapeutics, NexImmune, bluebird bio and Denali. Together they have raised over 19.1B between their estimated 408.4K employees. Relay has 330 employees and is ranked 10th among it's top 10 competitors. The top 10 competitors average 12,385.

Relay VS Eikon

Eikon is the biggest rival of Relay. Eikon was founded in 2019, and its headquarters is in Hayward, California. Eikon operates in the Biotechnology industry. Eikon has 282 fewer employees than Relay.

Relay VS GD3

GD3 has been one of Relay's top competitors. GD3 is a Private company that was founded in Hamilton, New Jersey in 1998. GD3 is in the Biotechnology industry. GD3 has 320 fewer employees vs. Relay.

Relay VS InSilico Medicine

InSilico Medicine is Relay's #3 rival. InSilico Medicine was founded in 2014 in Cambridge, Massachusetts. InSilico Medicine is in the Biotechnology field. InSilico Medicine generates $65M more revenue than Relay.

Looking for similar companies to Relay?

Similar Companies

Companies in Cambridge with employees in 250-500 range

See 132 companies 
Pharmaceuticals & Biotechnology companies in Cambridge

See 700 companies 
Pharmaceuticals & Biotechnology companies with employees in 250-500 range

See 677 companies 
Biotechnology companies in Cambridge

See 561 companies 
Biotechnology companies with employees in 250-500 range

See 340 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 
Biotechnology companies in Massachusetts

See 1,343 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,717 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Relay and Relay's Competitors

April 27, 2025FinanzNachrichten
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclon...
April 25, 2025StreetInsider
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of influenza virus, from an infecte...
April 25, 2025MobiHealthNews
Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs....
April 25, 2025Pharmaceutical Business Review
This initiative aims to harness biological and clinical insights, identify new drug targets, and create therapeutics for the oncology sector. The colla...
April 25, 2025Openpr
Global nephrology drugs market is estimated to be valued at USD 18.37 Bn in 2025 and is expected to reach USD 29.14 Bn by 2032, exhibiting a compound a...
April 25, 2025Pharmabiz
Pfizer Inc. will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical Oncology (ASCO)...
April 25, 2025Seeking Alpha
April 25, 2025Cambridge Independent
Sponsored feature | Slavé Petrovski, from AstraZeneca, celebrates DNA Day by delving into the world of genomics....
April 25, 2025Stockwatch
Symbol: PFE Security name: Pfizer CDR (CAD Hedged) Security type: depositary receipt Currency: Canadian dollar Distribution type: cash dividend (in Can...
April 26, 2025Forbes
CHONGQING, CHINA - APRIL 23: In this photo illustration, the logo of Pfizer Inc. is displayed on a ... More smartphone screen, with a stock market char...

Frequently Asked Questions about Relay

  1. Who are Relay's top competitors?

    Relay's top 3 competitors are Eikon, GD3, InSilico Medicine.

  2. Who is similar to Relay?

    Eikon is the most similar to Relay. GD3 and InSilico Medicine are also similar to Relay.

  1. Are Relay and Eikon competitors?

    Yes, Eikon is one of Relay’s top competitors.